Veterinary & Equine Product-Line Expansion
Adjacent-market product and operating leadership that adapted orthopedic and cryotherapy capabilities for veterinary and equine applications, then connected product development, testing, manufacturing, partner-brand fulfillment, pricing, and commercialization.
Results and contributions.
Operating context
PPI's orthopedic soft-goods, support, manufacturing, and cryotherapy capabilities created an opportunity to serve veterinary and equine markets, but the products and operating model had to fit different anatomy, use conditions, channels, and partner-brand requirements.
What made the work difficult
Entering the adjacent market required adapting products to different anatomy and use conditions. Testing, materials, manufacturing methods, pricing, partner-brand requirements, and fulfillment all had to stay coordinated.
Responsibility and authority
Dean led the business and operating strategy, directed product-development and manufacturing work, participated in design, material selection, testing, sourcing and tooling decisions, and developed pricing and commercialization approaches with partner-brand leadership.
How the work moved forward
- Developed the adjacent-market operating strategy and coordinated product adaptation for veterinary and equine use.
- Directed and reviewed product testing, material selection, sourcing, tooling, and manufacturing-method development.
- Integrated product and variant management with pricing, commercialization, partner coordination, and third-party fulfillment.
- Managed execution across engineering, production, purchasing, quality, graphics, IT, sales, and external veterinary/equine stakeholders.